Brief: Aridis' Pan-Coronavirus Monoclonal Antibody Cocktail Ar-701 Is Protective In Covid-19 Omicron Infected Animals
17/02/2022 13:41
Feb 17 (Reuters) - Aridis Pharmaceuticals Inc ARDS.O :
* ARIDIS' PAN-CORONAVIRUS MONOCLONAL ANTIBODY COCKTAIL
AR-701 IS
PROTECTIVE IN COVID-19 OMICRON INFECTED ANIMALS
* ARIDIS PHARMACEUTICALS INC - BOTH MABS CONFERRED COMPLETE
PROTECTION AGAINST OMICRON INFECTED ANIMALS WHEN GIVEN EITHER
PARENTERALLY OR BY INTRANASAL ADMINISTRATION
Source text for Eikon: ID:nPn3rkS2Va
Further company coverage: ARDS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aridis Pharmaceuticals
See all newsBrief: Aridis Pharmaceuticals Inc - On September 7 Nasdaq Announced That It Would Delist Common Stock Of Co
U.S. STOCKS ON THE MOVE-Pieris Pharma, Microsoft, Energy sector
U.S. STOCKS ON THE MOVE-Medtronic, Morgan Stanley, Bank of America
U.S. STOCKS ON THE MOVE-Teladoc Health, NVDIA, Chipotle
U.S. STOCKS ON THE MOVE-Pinterest, Sunrun, Tencent Music